509TiPA phase I dose-escalation and expansion trial of intratumorally administered CV8102, alone and in combination with anti-PD-1 in patients with advanced solid tumours J Krauss,T Eigentler, J Schreiber,C Weishaupt,P Terheyden,L Heinzerling,P Mohr,B Weide,S Ochsenreither,R Gutzmer,J C Becker,F Kiecker, F Funkner,R Heidenreich,S-K Kays,U Klinkhardt, U S Gnad-Vogt,B Scheel, O Schönborn-Kellenberger, T SeibelAnnals of Oncology（2019）引用 0|浏览65暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
